The 100 Top-cited Articles on Chronic Kidney Disease-mineral and Bone Disorder: A Bibliometric Analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Apr 19

PMID 38640280

Authors

Ting Kang

Haixia Mao

Dongmei Zhang

Dan Tang

Santao Ou

Affiliations

Soon will be listed here.

Abstract

Background: Tremendous scientific research has been conducted on chronic kidney disease-mineral and bone disorder (CKD-MBD), while only a few bibliometric analyses have been conducted in this field. In this study, we aim to identify 100 top-cited articles on CKD-MBD and analyze their main characteristics quantitatively.

Methods: Web of Science was used to search the 100 top-cited articles on CKD-MBD. The following data were extracted and analyzed from the selected articles: author, country of origin, institutions, article type, publication journal, publication year, citation frequency, and keywords.

Results: Among the 100 top-cited articles, the number of citations ranged between 181 to 2157, with an average number of citations of approximately 476. These articles were published in 23 different journals, with Kidney International publishing the most articles (n = 32). The largest contributor was the United States (n = 63), which was also the country that conducted the most collaborative studies with other nations. The University of Washington contributed the largest number of articles (n = 37). Block GA was the most common first-author (n = 7). The majority of articles were clinical research articles (n = 73), followed by reviews (n = 15). Although almost half of the articles had no keywords, the most concerned research direction was CKD-associated bone disease.

Conclusion: This is the first bibliometric study of the 100 top-cited articles on CKD-MBD. This study provides the main academic interests and research trends associated with CKD-MBD research.

References

Block G, Klassen P, Lazarus J, Ofsthun N, Lowrie E, Chertow G . Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15(8):2208-18. DOI: 10.1097/01.ASN.0000133041.27682.A2. View

Tong Y, Wang H, Cao X, Cai G, Chen X, Zhou J . Research hotspots and emerging trends of automated peritoneal dialysis: A bibliometric analysis from 2000 to 2020. Semin Dial. 2022; 36(2):117-130. DOI: 10.1111/sdi.13078. View

Schiffrin E, Lipman M, Mann J . Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007; 116(1):85-97. DOI: 10.1161/CIRCULATIONAHA.106.678342. View

Ellegaard O, Wallin J . The bibliometric analysis of scholarly production: How great is the impact?. Scientometrics. 2015; 105(3):1809-1831. PMC: 4643120. DOI: 10.1007/s11192-015-1645-z. View

. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2019; 7(1):1-59. PMC: 6340919. DOI: 10.1016/j.kisu.2017.04.001. View

Lee Y, Heo C, Park S, Kim Y, Park J, Kim I . Top 100 cited articles on hemodialysis: A bibliometric analysis. Medicine (Baltimore). 2021; 100(38):e27237. PMC: 10545359. DOI: 10.1097/MD.0000000000027237. View

Hruska K, Choi E, Memon I, Davis T, Mathew S . Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr Nephrol. 2009; 25(4):769-78. PMC: 3719392. DOI: 10.1007/s00467-009-1337-0. View

Blacher J, Guerin A, Pannier B, Marchais S, London G . Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001; 38(4):938-42. DOI: 10.1161/hy1001.096358. View

. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395(10225):709-733. PMC: 7049905. DOI: 10.1016/S0140-6736(20)30045-3. View

10.

Barreto F, Barreto D, Liabeuf S, Meert N, Glorieux G, Temmar M . Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009; 4(10):1551-8. PMC: 2758258. DOI: 10.2215/CJN.03980609. View

11.

Zhang Y, Jin D, Duan Y, Zhang Y, Duan L, Lian F . Bibliometric Analysis of Renal Fibrosis in Diabetic Kidney Disease From 1985 to 2020. Front Public Health. 2022; 10:767591. PMC: 8855938. DOI: 10.3389/fpubh.2022.767591. View

12.

Foreman K, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M . Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018; 392(10159):2052-2090. PMC: 6227505. DOI: 10.1016/S0140-6736(18)31694-5. View

13.

Goodman W, Goldin J, Kuizon B, Yoon C, Gales B, Sider D . Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342(20):1478-83. DOI: 10.1056/NEJM200005183422003. View

14.

Hruska K, Sugatani T, Agapova O, Fang Y . The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology. Bone. 2017; 100:80-86. PMC: 5502716. DOI: 10.1016/j.bone.2017.01.023. View

15.

Moe S, Drueke T, Lameire N, Eknoyan G . Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007; 14(1):3-12. DOI: 10.1053/j.ackd.2006.10.005. View

16.

Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama J . Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013; 17(3):247-88. DOI: 10.1111/1744-9987.12058. View

17.

Manchanda R, Varma R . Representation of authors and editors from poor countries: observed publication bias may reflect who is funding research. BMJ. 2004; 329(7457):110. PMC: 449828. DOI: 10.1136/bmj.329.7457.110. View

18.

Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J . Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012; 379(9818):815-22. DOI: 10.1016/S0140-6736(12)60033-6. View

19.

. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009; (113):S1-130. DOI: 10.1038/ki.2009.188. View

20.

Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H . Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant. 2003; 19(1):179-84. DOI: 10.1093/ndt/gfg513. View